In our experiments, we discovered for the first time that IFI16 overexpression activates transcription of IL6 in dual-luciferase assays and further induces activation of the PI3K/AKT pathway and EMT in ccRCC cells. Here, IFI16 is linked to nonpapillary renal cell carcinoma.